188 related articles for article (PubMed ID: 14763683)
1. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
Fountoulakis KN; Iacovides A; St Kaprinis G
Can J Psychiatry; 2004 Jan; 49(1):73-4. PubMed ID: 14763683
[No Abstract] [Full Text] [Related]
2. Efficacy of venlafaxine in the treatment of severe depression.
Kienke AS; Rosenbaum JF
Depress Anxiety; 2000; 12 Suppl 1():50-4. PubMed ID: 11098414
[TBL] [Abstract][Full Text] [Related]
3. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.
Koga M; Kodaka F; Miyata H; Nakayama K
Acta Psychiatr Scand; 2009 Oct; 120(4):329-31. PubMed ID: 19573048
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine and treatment-resistant depression.
Thase ME; Friedman ES; Howland RH
Depress Anxiety; 2000; 12 Suppl 1():55-62. PubMed ID: 11098415
[TBL] [Abstract][Full Text] [Related]
5. Sertraline versus venlafaxine XR in major depressive disorder.
Lusicic A; Jagadheesan K
J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
[No Abstract] [Full Text] [Related]
6. Medication-associated somnambulism.
Lange CL
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):211-2. PubMed ID: 15725964
[No Abstract] [Full Text] [Related]
7. Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.
Schwartz T; Jindal S; Virk S; Wade M
Psychosomatics; 2004; 45(3):217-9. PubMed ID: 15123846
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
10. Lithium augmentation in venlafaxine-refractory depression.
Zullino D; Preisig M; Baumann P
J Clin Psychopharmacol; 2001 Apr; 21(2):242-3. PubMed ID: 11270926
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
Sauer H; Huppertz-Helmhold S; Dierkes W
Pharmacopsychiatry; 2003 Sep; 36(5):169-75. PubMed ID: 14571350
[TBL] [Abstract][Full Text] [Related]
12. Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
Lin CH; Lin KS; Lin CY; Chen MC; Lane HY
J Clin Psychiatry; 2008 Jan; 69(1):54-9. PubMed ID: 18312038
[TBL] [Abstract][Full Text] [Related]
13. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
15. [Effects of venlafaxine extended release formulation on the clinical management of patients].
Carrasco JL; Díaz-Marsá M; López-Ibor JJ
Actas Esp Psiquiatr; 2005; 33(3):147-53. PubMed ID: 15918081
[TBL] [Abstract][Full Text] [Related]
16. Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
Jureidini J; Mintzes B
J Clin Psychiatry; 2008 May; 69(5):865-6; author reply 866. PubMed ID: 18681767
[No Abstract] [Full Text] [Related]
17. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Dell'Osso B; Nestadt G; Allen A; Hollander E
J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
[TBL] [Abstract][Full Text] [Related]
18. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
19. Venlafaxine: Successful treatment in impulsive disorders.
Camardese G; Picello A; Bria P
Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
